Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma. 30900377 2019
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Bcl-2 overexpression is commonly associated with various cancers including breast cancer, prostate cancer, B-cell lymphomas and colorectal adenocarcinomas etc. 31494078 2019
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Finally, Birinapant and AT-406 can synergise with BCL-2 inhibitor ABT-199 to reduce viability of adenocarcinoma cells with high BCL-2 expression. 27520705 2016
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE This study initially scheduled to determine the expression of bcl2 gene in tissue samples of adenocarcinoma cancer patients. 26320497 2015
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Expression of ITGB3 and BCL-2 in lung adenocarcinoma and adenocarcinoma cell line showed heterogeneity that expression in trailing edge was higher than that of trailing edge, which may play an important role in promoting tumor lymph node metastasis and vascular invasion, and provides a new research direction for exploration of lung adenocarcinoma metastasis mechanism. 25066397 2014
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE Whereas a balance was observed between the immunoreactivities of Bcl-2 and Bax in the borderline cases, and this balance was strongly changed toward the anti-apoptotic Bcl-2 protein in patients with adenocarcinoma. 25108507 2014
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Bcl-w a pro-survival member of the Bcl-2 protein family, is expressed in a variety of cancer types, including gastric and colorectal adenocarcinomas, as well as glioblastoma multiforme (GBM), the most common and lethal brain tumor type. 23826359 2013
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE The relationship between up-regulation of p53 and Bcl-2 and poorly differentiated ethmoidal adenocarcinoma suggests a role of these genes, in combination with additional genetic events, in the pathogenesis of ITAC. 21978692 2011
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group CTD_human Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. 21472143 2011
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE The balance between proliferation and apoptosis is represented by changes in the expression of the tissue markers, Bcl-2 and p53, and the presence of silver-stained nucleolar organizing regions (AgNOR) on DNA in prostate adenocarcinomas. 20146885 2010
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE Statistically significant associations between high Ki67 and poorly differentiated tumors (P = 0.016) and a smoking history (P = 0.053); p53 positivity and high Ki67 (P = 0.002); HER-2 positivity and adenocarcinoma subtype (P = 0.015) and presence of lymph node involvement (P = 0.006); and Bcl-2 positivity and squamous cell carcinoma subtype (P = 0.058) were observed. 18705409 2008
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group LHGDN Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma. 18516322 2008
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group LHGDN Analyses of Bcl-2, Survivin, and CD44v6 expressions and human papillomavirus infection in cervical carcinomas. 17464868 2007
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Expression of both bcl-2 and cox-2 were increased in non-dysplastic Barrett's (p = 0.0077, p = 0.0037), intraepithelial neoplasia (p = 0.0053, p = 0.0220) and adenocarcinoma (p < 0.0001, p < 0.0001) compared to squamous epithelium or reflux-esophagitis. 16550596 2006
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group LHGDN Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma. 16173075 2006
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE Multiple apoptotic stimuli induce conformational changes in Bax, a proapoptotic protein from the Bcl-2 family and its deficiency is a frequent cause of chemoresistance in colon adenocarcinomas. 15661804 2005
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Up-regulation of bcl-2 was found in all CAR-expressing adenocarcinomas of the murine cancer model. 15958612 2005
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Loss of pSer70 Bcl-2 expression was observed in adenocarcinomas in a differentiation-dependent manner (positivities: well differentiated 63%, moderately differentiated 52%, and poorly differentiated 12%), whereas tubular adenomas maintained their expression (positivity 88%). 16243795 2005
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE Meanwhile, the expressions of Bcl-2 and Bcl-x(L) protein and their mRNAs were significantly higher in adenocarcinoma tissues than that in adenomatous and normal epithelial tissues. 15484295 2004
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE In H pylori positive specimens, expressions of Bid and Bax did not correlate with that of Bcl-2 in adenocarcinoma tissues (Bid vs Bcl-2, r=0.187, P>0.05; Bax vs Bcl-2, r=0.201, P>0.05), but correlated positively with that of Bcl-2 respectively in resection margin tissues (Bid vs Bcl-2, r=0.331, P<0.05; Bax vs Bcl-2, r=0.295, P<0.05). 14716828 2004
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE This study investigated the prognostic significance of TUNEL, bcl-2, p53, proliferation marker Ki-67 and DNA mismatch repair (MMR) status in patients with Dukes' stage B2 and C colorectal adenocarcinomas. 15117979 2004
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group BEFREE A molecular understanding of both the progression of Barrett's esophagus and the factors determining the response of adenocarcinoma to neoadjuvant therapy is required, and this study focused on the role of proteins regulated by the bcl-2 family of genes, which are important regulators of programmed cell death (apoptosis). 12581249 2003
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group LHGDN A molecular understanding of both the progression of Barrett's esophagus and the factors determining the response of adenocarcinoma to neoadjuvant therapy is required, and this study focused on the role of proteins regulated by the bcl-2 family of genes, which are important regulators of programmed cell death (apoptosis). 12581249 2003
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 Biomarker group LHGDN Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species. 12046064 2002
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.400 AlteredExpression group BEFREE We comparatively assessed 41 mucinous colorectal carcinomas (MUCs) and 620 non-MUC (well-, moderately, and poorly differentiated adenocarcinoma) cases for clinicopathologic findings; and 41 MUCs and 115 randomly selected non-MUCs also were studied for the following: (1) apoptotic activity and Ki-67 immunoreactivity; (2) immunohistochemical expression of p21(WAF1/CIP1), p27Kip1, p53, and bcl-2; and (3) c-Ki-ras mutations. 12047142 2002